Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial

Photothermal therapy with nanoparticles is associated with a mean total atheroma volume reduction of 60.3 mm³ (p < 0.05) at 12 months with a target plaque burden of 37.8% (p < 0.05) which is below Glagov threshold and promising to revolutionize interventional vascular medicine.